vor: the income statement

MyFinsight

Vor Biopharma Inc. (VOR)

For the quarter ending 2025-06-30, VOR made $537K in revenue. -$1,573,678K in net income. Net profit margin of -293049.91%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Unrealized (loss) gain on available for sale marketable securities	-9
Total other comprehensive (loss) income	-9
Research and development	261,499
General and administrative	12,785
Total operating expenses	274,284
Loss from operations	-274,284
Interest income	537
Change in fair value of warrant liabilities	1,299,922
Total other (expense) income	-1,299,385
Net loss	-1,573,669
Comprehensive loss	-1,573,678

Earnings per share, basic, total	-12.56
Net loss per share attributable to common stockholders, diluted	-12.56
Weighted-average number of common shares outstanding, basic	125,271,447
Weighted-average number of common shares outstanding, diluted	125,271,447

Unit: Thousand (K) dollars (except for numbers of shares and EPS)